|
1
|
Shi Z, Li Y, Qian X, Hu Y, Liu J, Zhang S
and Zhang J: MiR-340 inhibits triple-negative breast cancer
progression by reversing EZH2 mediated miRNAs dysregulated
expressions. J Cancer. 8:3037–3048. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hawa Z, Haque I, Ghosh A, Banerjee S,
Harris L and Banerjee SK: The miRacle in pancreatic cancer by
miRNAs: Tiny angels or devils in disease progression. Int J Mol
Sci. 17:E8092016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang M, Matyunina LV, Walker LD, Chen W,
Xiao H, Benigno BB, Wu R and McDonald JF: Evidence for the
importance of post-transcriptional regulatory changes in ovarian
cancer progression and the contribution of miRNAs. Sci Rep.
7:81712017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pereira CM, Sehnem D, da Fonseca EO,
Barboza HFG, de Carvalho ACP, DaSilva AFM, Moura-Neto V and
DosSantos MF: miRNAs: Important targets for oral cancer pain
research. Biomed Res Int. 2017:40435162017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li L, Wang X, Li W, Yang L, Liu R, Zeng R,
Wu Y and Shou T: miR-21 modulates prostaglandin signaling and
promotes gastric tumorigenesis by targeting 15-PGDH. Biochem
Biophys Res Commun. 495:928–934. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang Q, Xu E, Dai J, Wu J, Zhang S, Peng B
and Jiang Y: miR-21 regulates
N-methyl-N-nitro-N'-nitrosoguanidine-induced
gastric tumorigenesis by targeting FASLG and BTG2.
Toxicol Lett. 228:147–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou B, Wang J, Zheng G and Qiu Z:
Methylated urolithin A, the modified ellagitannin-derived
metabolite, suppresses cell viability of DU145 human prostate
cancer cells via targeting miR-21. Food Chem Toxicol. 97:375–384.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang P, Guan Q, Zhou D, Yu Z, Song Y and
Qiu W: miR-21 inhibitors modulate biological functions of gastric
cancer cells via PTEN/PI3K/mTOR pathway. DNA Cell Biol. 37:38–45.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Frankel LB, Christoffersen NR, Jacobsen A,
Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is
an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou S, Zhang S, Wang Y, Yi S, Zhao L,
Tang X, Yu B, Gu X and Ding F: MiR-21 and miR-222 inhibit apoptosis
of adult dorsal root ganglion neurons by repressing TIMP3 following
sciatic nerve injury. Neurosci Lett. 586:43–49. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ferraro A, Kontos CK, Boni T, Bantounas I,
Siakouli D, Kosmidou V, Vlassi M, Spyridakis Y, Tsipras I, Zografos
G, et al: Epigenetic regulation of miR-21 in colorectal cancer:
ITGB4 as a novel miR-21 target and a three-gene network
(miR-21-ITGBeta4-PDCD4) as predictor of metastatic tumor potential.
Epigenetics. 9:129–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chanyshev MD, Ushakov DS and Gulyaeva LF:
Expression of miR-21 and its Acat1, Armcx1, and
PTEN target genes in liver of female rats treated with DDT
and benzo[a]pyrene. Mol Biol. 51:664–670. 2017.(In Russian).
View Article : Google Scholar
|
|
13
|
Guo Y, Chang H, Li J, Xu XY, Shen L, Yu ZB
and Liu WC: Thymosin alpha 1 suppresses proliferation and induces
apoptosis in breast cancer cells through PTEN-mediated inhibition
of PI3K/Akt/mTOR signaling pathway. Apoptosis. 20:1109–1121. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li XT, Wang HZ, Wu ZW, Yang TQ, Zhao ZH,
Chen GL, Xie XS, Li B, Wei YX, Huang YL, et al: miR-494-3p
regulates cellular proliferation, invasion, migration, and
apoptosis by PTEN/AKT signaling in human glioblastoma cells. Cell
Mol Neurobiol. 35:679–687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Y, Sun J, Cai Y, Jiang Y, Wang X, Huang
X, Yin Y and Li H: MiR-200a acts as an oncogene in colorectal
carcinoma by targeting PTEN. Exp Mol Pathol. 101:308–313. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao ZQ, Wang JF, Chen DH, Ma XS, Wu Y,
Tang Z and Dang XW: Long non-coding RNA GAS5 suppresses pancreatic
cancer metastasis through modulating miR-32-5p/PTEN axis. Cell
Biosci. 7:662017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sushma PS, Jamil K, Kumar PU,
Satyanarayana U, Ramakrishna M and Triveni B: PTEN and p16 genes as
epigenetic biomarkers in oral squamous cell carcinoma (OSCC): A
study on south Indian population. Tumour Biol. 37:7625–7632. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nan Y, Guo L, Song Y, Wang L, Yu K, Huang
Q and Zhong Y: Combinatorial therapy with adenoviral-mediated PTEN
and a PI3K inhibitor suppresses malignant glioma cell growth in
vitro and in vivo by regulating the PI3K/AKT signaling pathway. J
Cancer Res Clin Oncol. 143:1477–1487. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu X, Li Z, Li T, Long F, Lv Y, Liu L,
Liu X and Zhan Q: Osthole inhibits the PI3K/AKT signaling pathway
via activation of PTEN and induces cell cycle arrest and apoptosis
in esophageal squamous cell carcinoma. Biomed Pharmacother.
102:502–509. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen X, Huang Z and Chen R: Microrna-136
promotes proliferation and invasion ingastric cancer cells through
Pten/Akt/P-Akt signaling pathway. Oncol Lett. 15:4683–4689.
2018.PubMed/NCBI
|
|
21
|
Geletina NS, Kobelev VS, Babayants EV,
Feng L, Pustylnyak VO and Gulyaeva LF: PTEN negative correlates
with miR-181a in tumour tissues of non-obese endometrial cancer
patients. Gene. 655:20–24. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li B, Lu Y, Yu L, Han X, Wang H, Mao J,
Shen J, Wang B, Tang J, Li C and Song B: miR-221/222 promote cancer
stem-like cell properties and tumor growth of breast cancer via
targeting PTEN and sustained Akt/NF-κB/COX-2 activation. Chem Biol
Interact. 277:33–42. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Taghavi N and Yazdi I: Prognostic factors
of survival rate in oral squamous cell carcinoma: Clinical,
histologic, genetic and molecular concepts. Arch Iran Med.
18:314–319. 2015.PubMed/NCBI
|
|
24
|
Tamaki S, Kawakami M, Ishitani A,
Kawashima W, Kasuda S, Yamanaka Y, Shimomura H, Imai Y, Nakagawa Y,
Hatake K, et al: Soluble MICB serum levels correlate with disease
stage and survival rate in patients with oral squamous cell
carcinoma. Anticancer Res. 30:4097–4101. 2010.PubMed/NCBI
|
|
25
|
Li J, Huang H, Sun L, Yang M, Pan C, Chen
W, Wu D, Lin Z, Zeng C, Yao Y, et al: MiR-21 indicates poor
prognosis in tongue squamous cell carcinomas as an apoptosis
inhibitor. Clin Cancer Res. 15:3998–4008. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Koenig AB, Barajas JM, Guerrero MJ and
Ghoshal K: A comprehensive analysis of argonaute-clip data
identifies novel, conserved and species-specific targets of mir-21
in human liver and hepatocellular carcinoma. Int J Mol Sci.
19:E8512018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yan F, Wang C, Li T, Cai W and Sun J: Role
of miR-21 in the growth and metastasis of human salivary adenoid
cystic carcinoma. Mol Med Rep. 17:4237–4244. 2018.PubMed/NCBI
|
|
28
|
Wu Y, Song Y, Xiong Y, Wang X, Xu K, Han
B, Bai Y, Li L, Zhang Y and Zhou L: MicroRNA-21 (Mir-21) promotes
cell growth and invasion by repressing tumor suppressor PTEN in
colorectal cancer. Cell Physiol Biochem. 43:945–958. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jung S, Li C, Jeong D, Lee S, Ohk J, Park
M, Han S, Duan J, Kim C, Yang Y, et al: Oncogenic function of
p34SEI-1 via NEDD41 mediated PTEN
ubiquitination/degradation and activation of the PI3K/AKT pathway.
Int J Oncol. 43:1587–1595. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang L, Tang B, Han H, Mao D, Chen J, Zeng
Y and Xiong M: miR-155 affects osteosarcoma MG-63 cell autophagy
induced by adriamycin through regulating PTEN-PI3K/AKT/mTOR
signaling pathway. Cancer Biother Radiopharm. 33:32–38. 2018.
View Article : Google Scholar : PubMed/NCBI
|
